Personal fairness agency Apiary Capital backs fast progress of performance-i
Apiary Capital has accomplished its funding in performance-io (PIO), a number one life sciences efficiency advertising and search engine marketing company, supporting its worldwide enlargement and repair progress.
London-based PIO employs greater than 60 folks globally, with groups throughout the UK, US, India, Japan and South Africa. Since launching in 2018, it has established itself as the primary specialist website positioning company working within the regulated pharma house.
CEO and founder Matt Lowe mentioned: “for me it was about time out there and timing the market. We have now in no small method created {the marketplace} for website positioning in pharma and it felt like the precise time to seek out the precise companion to make sure we set up ourselves because the International normal in on-line efficiency, website positioning and optimized content material. After an extended and deliberate course of, we’re satisfied the staff at Apiary would be the good companions for PIO.”
Apiary’s funding will speed up PIO’s enlargement within the US and Japan and assist the adoption of AI-enabled website positioning options. PIO is pioneering search generative expertise (SGE) methods that assist shoppers maximize on-line efficiency whereas chopping prices.
CCO Jason Brown mentioned: “PIO is completely positioned to develop our market providing consistent with the demand from our shoppers, all of whom are attempting to harness new and evolving AI applied sciences to drive efficiencies while driving progress.”
The funding comes from Apiary’s second fund, which closed in 2024. Jess French, director at Apiary, mentioned: “We’re extremely excited to companion with Matt, Jason, and all the PIO staff. That is precisely the sort of enterprise Apiary seeks to spend money on: founder-led, clearly differentiated, and targeted on delivering actual, measurable worth to its shoppers.”
Personal fairness agency Apiary Capital backs fast progress of performance-i
Apiary Capital has accomplished its funding in performance-io (PIO), a number one life sciences efficiency advertising and search engine marketing company, supporting its worldwide enlargement and repair progress.
London-based PIO employs greater than 60 folks globally, with groups throughout the UK, US, India, Japan and South Africa. Since launching in 2018, it has established itself as the primary specialist website positioning company working within the regulated pharma house.
CEO and founder Matt Lowe mentioned: “for me it was about time out there and timing the market. We have now in no small method created {the marketplace} for website positioning in pharma and it felt like the precise time to seek out the precise companion to make sure we set up ourselves because the International normal in on-line efficiency, website positioning and optimized content material. After an extended and deliberate course of, we’re satisfied the staff at Apiary would be the good companions for PIO.”
Apiary’s funding will speed up PIO’s enlargement within the US and Japan and assist the adoption of AI-enabled website positioning options. PIO is pioneering search generative expertise (SGE) methods that assist shoppers maximize on-line efficiency whereas chopping prices.
CCO Jason Brown mentioned: “PIO is completely positioned to develop our market providing consistent with the demand from our shoppers, all of whom are attempting to harness new and evolving AI applied sciences to drive efficiencies while driving progress.”
The funding comes from Apiary’s second fund, which closed in 2024. Jess French, director at Apiary, mentioned: “We’re extremely excited to companion with Matt, Jason, and all the PIO staff. That is precisely the sort of enterprise Apiary seeks to spend money on: founder-led, clearly differentiated, and targeted on delivering actual, measurable worth to its shoppers.”
